Andrew H. Lichtman MD, PhD

Member Scientific Advisory Board

Dr. Lichtman is Professor of Pathology at the Brigham and Women’s Hospital and Harvard Medical School, where he has been a staff anatomic pathologist and a principal investigator for over 35 years. His research has been in the fields of immunology and vascular biology. He is an expert on T cell biology, including trafficking, activation, and regulation by checkpoint inhibitors, and the role of T cell mediated immune responses in cardiovascular disease.

Andrew Lichtman received and M.D. and Ph.D. degrees from the University of Rochester School of Medicine in 1981, trained in Anatomic Pathology at the Brigham and Women’s Hospital (BWH) 1982-1985, followed by a postdoctoral research fellowship in Abul Abbas’ lab at the BWH. He is a board-certified Anatomic Pathologist and is currently Professor of Pathology at BWH and Harvard Medical School (HMS).

He has been conducting basic biomedical laboratory research for over 37 years and has been a PI or Project leader on multiple NIH-funded grants. He has authored over 140 primary research or invited review journal articles. His laboratory has made significant contributions in the fields of lymphocyte-endothelial interactions, T cell subset biology, and immune/inflammatory aspects of cardiovascular disease (CVD).

His work in CVD has focused on the role of T cell subsets in the pathogenesis of atherosclerosis and myocarditis, and the impact of cytokines, lymphoid subsets, and costimulatory and immune check point molecules on arterial and myocardial inflammation. Recent projects in his lab have addressed the role of the PD-1/PDL-1 and LAG-3 pathways in cardiovascular disease and the impact of autoimmunity on atherosclerosis in type 1 diabetes.

Dr. Lichtman has served as charter member of an NHLBI Study Section, chaired the Cardiovascular, Diabetes and Metabolic Disorders Research Group of the BWH Biomedical Research Institute, and served as both Education and Publication Chair of the Federation of Clinical Immunology Societies (FOCIS). He has been an associate editor of several journals. Dr. Lichtman has actively participated in the Harvard Medical School M.D. curriculum for over 40 years, including directing and teaching in Immunology and Pathology courses, and serving on curricular reform leadership committees.

He has been a principal coauthor of 15 editions of two textbooks of Immunology, which have been translated in 12 languages and used worldwide. He has been active internationally in immunology and medical education, having taught courses in 6 continents and participating in curricular development in medical schools in Africa and Viet Nam. He has received many teaching and mentoring awards at HMS and is the 2014 recipient of the American Society of Investigative Pathology Distinguished Educator Award.